Skip to content

Author

Dhruv Gehlot

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Regenerative failure in metabolic dysfunction-associated steatohepatitis: The entrapped progenitor model and precision repair

Metabolic dysfunction-associated steatohepatitis (MASH), the progressive inflammatory subtype of metabolic dysfunction-associated steatotic liver disease (MASLD), has emerged as a leading cause of cirrhosis and hepatocellular carcinoma. Despite recent Food and Drug Administration approval of metabolic modulators, l...

Dhruv Gehlot, Swayam Bakriwala, Y. Patel · 0 citations
Review Sep 2026

Efficacy and cardiovascular safety of lasmiditan in patients with cardiovascular risk factors: A systematic review and meta-analysis with updated synthesis of triptan safety data.

OBJECTIVE This study was conducted to evaluate lasmiditan efficacy and cardiovascular (CV) safety in patients with CV risk factors, and provide an updated synthesis of observational evidence on long-term triptan-related CV outcomes. BACKGROUND Approximately 20% of patients with migraine have CV contraindications to t...

Shankar Biswas, S. Vasireddy, Yashasvi Srivastava et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.